Seeking AlphaSat, 09 May 2026 18:21:13 GMTenGene Therapeutics Inc. (ENGN) Discusses Pivotal Cohort Data from LEGEND Trial of Detalimogene in High-Risk NMIBC TranscriptENGN+6.94%
MarketBeatFri, 08 May 2026 23:06:01 GMTenGene Bladder Cancer Data Shows Promise, but Durability Questions RemainENGN+6.94%
Seeking AlphaTue, 10 Mar 2026 20:40:16 GMTenGene Holdings Inc. (ENGN) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptENGN+6.94%